Scientific knowledge base
Search structured peptide profiles by molecule class, research area, evidence level, development stage and regulatory status. Product listings and scientific classification remain deliberately separate.
This database is an information and classification system. It provides no dosing, sourcing or administration recommendations.
Research area
Peptides studied in models of cell migration, matrix organisation, wound healing and tissue repair.
Pathways related to glucose homeostasis, appetite, energy expenditure and body composition.
Peptide hormones and analogues related to hypothalamic, pituitary and peripheral endocrine systems.
Mitochondrial peptides, cellular stress, bioenergetics and age-associated pathways.
Neuropeptides and analogues in models of neuronal signalling, stress and pain.
Innate immunity, epithelial barriers and antimicrobial peptide functions.
Skin matrix, pigmentation biology, copper peptides and melanocortin signalling.
Peptide signals related to reproductive axes, social behaviour and sexual function.
Peptide-based regulation of secretion, motility and the intestinal barrier.
Peptide therapeutics for molecularly defined rare diseases and specialised treatment concepts.
Peptide analogue
Semaglutide; GLP-1 receptor agonist
Semaglutide is a modified GLP-1 analogue used in authorised medicines for defined metabolic indications.
Peptide analogue
Tirzepatide; dual GIP/GLP-1 receptor agonist
Tirzepatide is a long-acting peptide analogue with dual GIP and GLP-1 receptor activity used in authorised medicines.
Peptide analogue
Egrifta; growth hormone-releasing factor analogue
Tesamorelin is a stabilised GHRH analogue with a specific U.S. approval for a narrowly defined indication.
Cyclic peptide
Setmelanotide; RM-493; Imcivree
Setmelanotide is a cyclic MC4R agonist used in authorised medicines for selected genetically defined forms of obesity.
Peptide analogue
Retatrutide; LY3437943; triple agonist
Retatrutide is an investigational peptide analogue activating GIP, GLP-1 and glucagon receptors and is being studied in phase III programmes.
Mitochondrial peptide
Mitochondrial open reading frame of the 12S rRNA-c
MOTS-c is a mitochondrially encoded 16-amino-acid peptide investigated as a signal linking mitochondria, nucleus and metabolism.
Peptide analogue
Liraglutide; GLP-1 receptor agonist
Liraglutide is a long-acting GLP-1 analogue with authorised medicinal uses in defined metabolic indications.
Synthetic peptide
Pralmorelin; KP-102
GHRP-2 is a synthetic hexapeptide and ghrelin-receptor agonist studied mainly as an endocrine research and diagnostic tool.
Peptide analogue
CJC-1295 DAC; modified GRF(1-29)
CJC-1295 refers to modified GHRH analogues; scientific assessment must distinguish DAC from non-DAC variants.
Synthetic peptide
Ipamorelin acetate; NNC 26-0161
Ipamorelin is a synthetic pentapeptide investigated as a ghrelin-receptor agonist in endocrine and pharmacological studies.
Synthetic peptide
Growth hormone-releasing peptide-6
GHRP-6 is a synthetic hexapeptide studied in early human and animal work on growth-hormone secretion and appetite signalling.
